Semaglutide has emerged as a promising treatment for insulin resistance. This synthetic glucagon-like peptide-1 (GLP-1) receptor agonist acts upon stimulating the pancreas to produce more insulin and reducing glucagon https://umairhtsl177606.blogpixi.com/35928419/grasping-semaglutide-a-comprehensive-guide